Effect of Oxygen on Phosphodiesterases (PDE) 3 and 4 Isoforms and PKA Activity in the Superior Cervical Ganglia

Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 758)


The cAMP-protein kinase A (PKA) signaling pathway is involved in regulating the release of transmitters from neurons and other cells. Multiple phosphodiesterase (PDE) isoforms regulate this pathway, however, the pattern of isoform expression and stimulus response across tissues has not been fully characterized.

Using fluorescent resonance energy transfer (FRET)-based imaging in primary superior cervical ganglia (SCG) neurons and real-time qPCR, we explored the role of PDE3 and PDE4 isoforms and oxygen tension in the activation of PKA and changes in gene expression. These primary neurons were infected with an adenovirus containing A-Kinase activity reporter (AKAR3) and assayed for responses to PDE inhibitors: rolipram (ROL, 1 μM), milrinone (MIL, 10 μM) and IBMX (100 μM), and adenylyl cyclase activator forskolin (FSK, 50 μM). Different PDE activity patterns were observed in different cells: high PDE4 activity (n = 3), high PDE3 activity (n = 3) and presence of activity of other PDEs (n = 3). Addition of PKA inhibitor H89 (10 μM) completely reversed the response. We further studied the effect of oxygen in the PKA activity induced by PDE inhibition. Both normoxia (20%O2/5%CO2) and hypoxia (0%O2/5%CO2) induced a similar increase in the FRET emission ratio (14.5 ± 0.8 and 14.7 ± 0.8, respectively).

PDE3a, PDE4b and PDE4d isoforms mRNAs were highly expressed in the whole SCG with no modulation by hypoxia.

CONCLUSION: Using a FRET-based PKA activity sensor, we show that primary SCG neurons can be used as a model system to dissect the contribution of different PDE isoforms in regulating cAMP/PKA signaling. The differential patterns of PDE regulation potentially represent subpopulations of ganglion cells with different physiological functions.


Superior cervical ganglia (SCG) Phosphodiesterases (PDE) Cyclic AMP (cAMP) Hypoxia Protein kinase A (PKA) 



A.R. Nunes was supported by the Portuguese Fundacao de Ciencia e Tecnologia (FCT, SFRH/BD/39473/2007). This work is also supported by NIH R01 DK073368 (to JZ) and HL082846 (to YKX).


  1. Asamoto K (2005) Network of the sympathetic nervous system: focus on the input and output of the cervical sympathetic ganglion. Anat Sci Int 80:132–140PubMedCrossRefGoogle Scholar
  2. Bender AT, Beavo JA (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58:488–520PubMedCrossRefGoogle Scholar
  3. Giorgi M, Squitti R, Bonsi P, Paggi P, Toschi G (1994) Activities of 3’5’ cyclic nucleotide phophodiesterases in the superior cervical ganglion of rat: characterization, compartmentalization and observation in young and old animals. Neurochem Int 25(5):493–500PubMedCrossRefGoogle Scholar
  4. Lakics V, Karran EH, Boess FG (2010) Quantitative comparison of phosphodiesterase mRNA distribution in human brain an peripheral tissues. Neuropharmacol 59:367–374CrossRefGoogle Scholar
  5. Li C, Horn JP (2006) Physiological classification of sympathetic neurons in the rat SCG. J Neurophysiol 95:187–195PubMedCrossRefGoogle Scholar
  6. Nunes AR, Batuca JR, Monteiro EC (2010) Acute hypoxia modifies cAMP levels induced by inhibitors of phosphodiesterase-4 in rat carotid bodies, carotid arteries and superior cervical ganglia. Br J Pharmacol 159:353–361PubMedCrossRefGoogle Scholar
  7. Perez-Garcia MT, Almaraz L, Gonzalez C (1990) Effects of different types of stimulation on cyclic AMP content in the rabbit carotid body: functional significance. J Neurochem 55:1287–1293PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Ana Rita Nunes
    • 1
    • 2
  • Vedangi Sample
    • 3
  • Yang K. Xiang
    • 4
  • Emília C. Monteiro
    • 5
  • Estelle Gauda
    • 1
  • Jin Zhang
    • 3
    • 6
  1. 1.Department of PediatricsJohns Hopkins University, School of MedicineBaltimoreUSA
  2. 2.CEDOC, Departamento de Farmacologia, Faculdade de Ciências MédicasUniversidade NOVA de LisboaLisbonPortugal
  3. 3.Department of Pharmacology and Molecular SciencesJohns Hopkins University, School of MedicineBaltimoreUSA
  4. 4.Department of Molecular and Integrative PhysiologyUniversity of Illinois at UrbanaUrbanaUSA
  5. 5.CEDOC, Departamento de Farmacologia, Faculdade de Ciências MédicasUniversidade NOVA de LisboaLisbonPortugal
  6. 6.Department of Neuroscience and OncologyJohns Hopkins University, School of MedicineBaltimoreUSA

Personalised recommendations